Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.53 |
| ▸ | FAP | Q12884 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14504943 | 0.90 | DPP4 (0.56) | DPP4FAP | |
| SCHEMBL5428421 | 0.89 | DPP4 (0.51) | DPP4 | |
| SCHEMBL3893526 | 0.84 | DPP4 (0.62) | DPP4FAPCYP3A4 | |
| SCHEMBL2201252 | 0.82 | DPP4 (0.57) | DPP4FAPCYP3A4 | |
| SCHEMBL5430855 | 0.81 | DPP4 (0.48) | DPP4 | |
| SCHEMBL5436756 | 0.81 | DPP4 (0.48) | DPP4 | |
| SCHEMBL5471562 | 0.81 | DPP4 (0.64) | DPP4FAP | |
| SCHEMBL5437139 | 0.80 | DPP4 (0.74) | DPP4FAP | |
| SCHEMBL5433031 | 0.79 | DPP4 (0.66) | DPP4FAP | |
| SCHEMBL3897399 | 0.79 | DPP4 (0.46) | DPP4FAPCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070105890-A1 | Novel condensed imidazole derivative | DAINIPPON SUMITOMO PHARMA CO., LTD | 2007-05-10 | — | — | US | disclosed |
| EP-1690863-A1 | NOVEL CONDENSED IMIDAZOLE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2006-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105890-A1 | Novel condensed imidazole derivative | DPP4, DPP7, DPP3 | DPP4 1/4885FAP 346/4885CYP3A4 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.